Rhythm Pharmaceuticals, Inc. RYTM Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s total equity?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported total equity of $122.91M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s total equity changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s total equity increased by 548.7% year-over-year, from $18.95M to $122.91M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s total equity?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s total equity has grown at a -3.5% compound annual growth rate (CAGR), from $166.53M to $139.07M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.